Aquestive Therapeutics, Inc. (AQST) earnings date

Nasdaq · Small cap · EDGAR filings

Email me when this date changes · free account, one click to stop

How this company behaves

Announces its report date Not enough announcements on file yet to say
Reports after the quarter ends 42 days, typically, give or take 11 (last 8 releases)

Last 8 releases

PeriodReleasedTimingDays after period endFiling
Q3 FY2026Tue, Nov 3, 2026after close 34 8-K
Q2 FY2026Tue, Aug 11, 2026after close 42 8-K
Q1 FY2026Wed, May 13, 2026after close 43 8-K
Q4 FY2025Wed, Mar 4, 2026after close 63 8-K
Q3 FY2025Wed, Nov 5, 2025after close 36 8-K
Q2 FY2025Mon, Aug 11, 2025after close 42 8-K
Q1 FY2025Mon, May 12, 2025after close 42 8-K
Q4 FY2024Wed, Mar 5, 2025after close 64 8-K

What they guided beta

Q3 FY2026 "Ex-U.S. Anaphylm strategy progressing, with Health Canada submission expected in Q4 2026 and an EU filing planned for Q1 2027" exhibit
Q3 FY2026 "Outside the U.S., the Company expects to submit a New Drug Submission to Health Canada in Q4 2026 and plans to file in the European Union in Q1 2027." exhibit
Q3 FY2026 "The Company expects to conduct additional clinical work beginning in the first quarter of 2027." exhibit
Q3 FY2026 "License and royalty revenue decreased to $0.8 million in the third quarter 2026 from $1.0 million in the third quarter 2025, primarily due to lower estimated royalty revenues." exhibit
Q3 FY2026 "Cash and cash equivalents were $90.3 million as of September 30, 2026. 2026 Outlook Aquestive's full-year 2026 financial guidance remains unchanged." exhibit
Q2 FY2026 "Remains on track to resubmit Anaphylm NDA to the FDA in Q3 2026" exhibit
Q2 FY2026 "On track to begin ex-U.S. filings of Anaphylm in Q4 2026" exhibit
Q2 FY2026 "The Company reaffirms its guidance to resubmit the Anaphylm New Drug Application (NDA) in the third quarter of 2026." exhibit
Q2 FY2026 "The Company remains on track to submit regulatory applications in Canada by the end of 2026 and in the European Union in the first quarter of 2027." exhibit
Q2 FY2026 "The Company expects its existing clinical data to support regulatory submissions in additional markets in 2027, including the United Kingdom." exhibit

Get this as JSON

curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/AQST
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/AQST

Put this date on your page

A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.

Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.

AQST earnings date badge

HTML

<a href="https://veritasdata.dev/company/AQST/"><img src="https://veritasdata.dev/embed/AQST.svg" alt="AQST earnings date" width="240" height="56"></a>

Markdown

[![AQST earnings date](https://veritasdata.dev/embed/AQST.svg)](https://veritasdata.dev/company/AQST/)

Script

<script async src="https://veritasdata.dev/embed/AQST.js"></script>

Get a free key: 100 calls, every company

Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.

curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/AQST"

Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.